Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mei-Feng,Ye

第一单位： Guangzhou Medical University, Guangzhou, China.

作者： Mei-Feng,Ye ^[1] ; Shan,Su ^[2] ; Zhi-Hao,Huang ^[2] ; Jian-Jun,Zou ^[2] ; Duo-Hua,Su ^[3] ; Xiao-Hui,Chen ^[4] ; Long-Feng,Zeng ^[3] ; Wei-Xiang,Liao ^[3] ; Hui-Yi,Huang ^[2] ; Yun-Yun,Zeng ^[2] ; Wen-Chang,Cen ^[2] ; Xian-Lan,Zhang ^[2] ; Chun-Xin,Liao ^[3] ; Jian,Zhang ^[5] ; Yan-Bin,Zhang ^[3]

作者单位： Guangzhou Medical University, Guangzhou, China. ^[1] Department of Oncology, Guangzhou Chest Hospital, Guangzhou, China. ^[2] Department of Tuberculosis, Guangzhou Chest Hospital, Guangzhou, China. ^[3] Department of Thoracic Surgery, Guangzhou Chest Hospital, Guangzhou, China. ^[4] Department of Oncology, Zhujiang Hospital, Guangzhou, China. ^[5]

关键词 Lung cancer chemotherapy pulmonary tuberculosis (pulmonary TB)

DOI 10.21037/atm-20-5964

PMID 33240992

发布时间 2022-04-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of translational medicine

2020年8卷18期

1143页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

检索历史清除